Podcast: A Few Words With Acting FDA Commish Stephen Ostroff
This article was originally published in The Gray Sheet
In this podcast, Acting FDA Commissioner Stephen Ostroff speaks to “The Gray Sheet” following his April 20 keynote at the Food and Drug Law Institute’s annual conference in Washington, D.C. He hopes to maintain the momentum set by former commissioner Margaret Hamburg, and to continue a focus on speeding up premarket reviews. But it's too early to talk about staying on permanently as commissioner, he cautioned.
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.